NCT04815850View on ClinicalTrials.gov

Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 15, 2022

Study Completion Date

December 5, 2022

Conditions
End Stage Kidney Disease
Trial Locations (1)

LE5 4PW

University Hospital Leicester NHS Trust, Leicester

All Listed Sponsors
collaborator

Leicester Hospitals Charity

OTHER

collaborator

Francis Crick Institute

OTHER

lead

University of Leicester

OTHER

NCT04815850 - Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study | Biotech Hunter | Biotech Hunter